When is a wearable defibrillator indicated?

References

• Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death–executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006;27:2099–2140.
   PubMed Web of Science ®Google Scholar
• Zoll PM, Linenthal AJ, Gibson W, et al. Termination of ventricular fibrillation in man by externally applied electric countershock. N Engl J Med. 1956;254:727–732.
   PubMed Web of Science ®Google Scholar
• Mirowski M, Mower MM, Reid PR. Treatment of malignant ventricular arrhythmias in man with an implanted automatic defibrillator. Crit Care Med. 1981;9:388–389.
   PubMed Web of Science ®Google Scholar
• Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793–2867.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Zelenkofske S, McMurray JJV, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352(25):2581–2588.
   PubMed Web of Science ®Google Scholar
• Kutyifa V, Moss AJ, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II Registry). Circulation. 2015;132:1613–1619.
   PubMed Web of Science ®Google Scholar
• Masri A, Altibi AM, Erqou S, et al. Wearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. JACC Clin Electrophysiol. 2019;5:152–161.
   PubMedGoogle Scholar
• Garcia R, Combes N, Defaye P, et al. Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study. Europace. 2020;23:73–81.
   Web of Science ®Google Scholar
• Olgin JE, Lee BK, Vittinghoff E, et al. Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: as-treated and per-protocol analyses. J Cardiovasc Electrophysiol. 2020;31:1009–1018.
   PubMed Web of Science ®Google Scholar
• Epstein AE, Abraham WT, Bianco NR, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62:2000–2007.
   PubMed Web of Science ®Google Scholar
• Chung MK, Szymkiewicz SJ, Shao M, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56:194–203.
   PubMed Web of Science ®Google Scholar
• Wäßnig NK, Günther M, Quick S, et al. Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circulation. 2016;134:635–643.
   PubMed Web of Science ®Google Scholar
• Ellenbogen KA, Koneru JN, Sharma PS, et al. Benefit of the wearable cardioverter-defibrillator in protecting patients after implantable-cardioverter defibrillator explant: results from the national registry. JACC Clin Electrophysiol. 2017;3:243–250.
   PubMedGoogle Scholar
• Veltmann C, Winter S, Duncker D, et al. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-Europe registry. Clin Res Cardiol Off J Ger Card Soc. 2021;110:102–113.
   PubMed Web of Science ®Google Scholar
• Mueller-Leisse J, Brunn J, Zormpas C, et al. Extended follow-up after wearable cardioverter-defibrillator period: the PROLONG-II study. ESC Heart Fail. 2021. https://onlinelibrary.wiley.com/doi/full/https://doi.org/10.1002/ehf2.13586.
   Google Scholar
• Singh M, Wang NC, Jain S, et al. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy: a decade-long single-center experience. J Am Coll Cardiol. 2015;66:2607–2613.
   PubMed Web of Science ®Google Scholar
• Zishiri ET, Williams S, Cronin EM, et al. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2013;6:117–128.
   PubMed Web of Science ®Google Scholar
• Olgin JE, Pletcher MJ, Vittinghoff E, et al. Wearable cardioverter–defibrillator after myocardial infarction. N Engl J Med. 2018;379:1205–1215.
   PubMed Web of Science ®Google Scholar
• Lackermair K, Schuhmann CG, Kubieniec M, et al. Impairment of quality of life among patients with wearable cardioverter defibrillator therapy (LifeVest®): a preliminary study. BioMed Res Int. 2018;2018:6028494.
   PubMed Web of Science ®Google Scholar
• Reek S, Burri H, Roberts PR, et al. The wearable cardioverter-defibrillator: current technology and evolving indications. EP Eur. 2017;19:335–345.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary. Circulation. 2018;138:e210–e271.
   PubMed Web of Science ®Google Scholar
• Kalarus Z, Svendsen JH, Capodanno D, et al. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol. 2019;21:1603–1604.
   Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42:3599–3726.
   PubMed Web of Science ®Google Scholar
• Erath JW, Vamos M, Benz AP, et al. Usefulness of the WCD in patients with suspected tachymyopathy. Clin Res Cardiol Off J Ger Card Soc. 2018;107:70–75.
   PubMed Web of Science ®Google Scholar
• Owen HJ, Bos JM, Ackerman MJ. Wearable cardioverter defibrillators for patients with long QT syndrome. Int J Cardiol. 2018;268:132–136.
   PubMed Web of Science ®Google Scholar
• Klein HU, Goldenberg I, Moss AJ. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Eur Heart J. 2013;34:2230–2242.
   PubMed Web of Science ®Google Scholar
• Collins KK, Silva JNA, Rhee EK, et al. Use of a wearable automated defibrillator in children compared to young adults. Pacing Clin Electrophysiol PACE. 2010;33:1119–1124.
   PubMed Web of Science ®Google Scholar
• Spar DS, Bianco NR, Knilans TK, et al. The US experience of the wearable cardioverter-defibrillator in pediatric patients. Circ Arrhythm Electrophysiol. 2018;11:e006163.
   PubMed Web of Science ®Google Scholar
• Daimee UA, Vermilye K, Moss AJ, et al. Experience with the wearable cardioverter-defibrillator in older patients: results from the prospective registry of patients using the wearable cardioverter-defibrillator. Heart Rhythm. 2018;15:1379–1386.
   PubMed Web of Science ®Google Scholar
• Kaspar G, Sanam K, Gholkar G, et al. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD. Int J Cardiol. 2018;272:179–184.
   PubMed Web of Science ®Google Scholar
• Clark MA, Szymkiewicz SJ, Volosin K. Mortality and costs associated with wearable cardioverter-defibrillators after acute myocardial infarction: a retrospective cohort analysis of medicare claims data. J Innov Card Rhythm Manag. 2019;10:3866–3873.
   PubMedGoogle Scholar
• Boriani G, Mantovani LG, Cortesi PA, et al. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: clinical and economic implications. Clin Cardiol. 2021;44(11):1497–1505.
   PubMed Web of Science ®Google Scholar